−0.0007 USD
−568.77 K USD
3.00 K USD
578.91 M
About Pharmagreen Biotech Inc.
Sector
CEO
Peter Wojcik
Website
Headquarters
Coquitlam
Founded
2007
FIGI
BBG000H1CL35
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHBI is 0.0029 USD — it has increased by 9.43% in the past 24 hours. Watch Pharmagreen Biotech Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pharmagreen Biotech Inc. stocks are traded under the ticker PHBI.
PHBI stock has risen by 31.82% compared to the previous week, the month change is a −21.62% fall, over the last year Pharmagreen Biotech Inc. has showed a 314.29% increase.
PHBI reached its all-time high on Nov 21, 2012 with the price of 196.0000 USD, and its all-time low was 0.0003 USD and was reached on Oct 12, 2023. View more price dynamics on PHBI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHBI stock is 16.00% volatile and has beta coefficient of −0.43. Track Pharmagreen Biotech Inc. stock price on the chart and check out the list of the most volatile stocks — is Pharmagreen Biotech Inc. there?
Today Pharmagreen Biotech Inc. has the market capitalization of 1.76 M, it has decreased by −4.00% over the last week.
Yes, you can track Pharmagreen Biotech Inc. financials in yearly and quarterly reports right on TradingView.
PHBI net income for the last quarter is −42.52 K USD, while the quarter before that showed −37.95 K USD of net income which accounts for −12.03% change. Track more Pharmagreen Biotech Inc. financial stats to get the full picture.
No, PHBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmagreen Biotech Inc. EBITDA is −288.48 K USD, and current EBITDA margin is −15.81 K%. See more stats in Pharmagreen Biotech Inc. financial statements.
Like other stocks, PHBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmagreen Biotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmagreen Biotech Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmagreen Biotech Inc. stock shows the sell signal. See more of Pharmagreen Biotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.